218 related articles for article (PubMed ID: 24194912)
21. Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications.
Park SH; Jang KY; Kim MJ; Yoon S; Jo Y; Kwon SM; Kim KM; Kwon KS; Kim CY; Woo HG
Oncotarget; 2015 Dec; 6(42):44819-31. PubMed ID: 26540566
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma.
Keshari RP; Wang W; Zhang Y; Wang DD; Li YF; Yuan SQ; Qiu HB; Huang CY; Chen YM; Xia JC; Zhou ZW
PLoS One; 2014; 9(2):e87195. PubMed ID: 24504018
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance.
Zhu XJ; Gao SG; Li SQ; Shi ZG; Ma ZK; Zhu SS; Feng XS
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):391-8. PubMed ID: 25582300
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis.
Huang CY; Chen YM; Zhao JJ; Chen YB; Jiang SS; Yan SM; Zhao BW; Pan K; Wang DD; Lv L; Li YF; Wang W; Zhou ZW; Xia JC
PLoS One; 2013; 8(1):e54671. PubMed ID: 23372750
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
28. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.
Xu TP; Huang MD; Xia R; Liu XX; Sun M; Yin L; Chen WM; Han L; Zhang EB; Kong R; De W; Shu YQ
J Hematol Oncol; 2014 Aug; 7():63. PubMed ID: 25167886
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic implications of FOXO3a and Ki67 in lung adenocarcinomas.
Liu HB; Gao XX; Zhang Q; Liu J; Cui Y; Zhu Y; Liu YF
Asian Pac J Cancer Prev; 2015; 16(4):1443-8. PubMed ID: 25743813
[TBL] [Abstract][Full Text] [Related]
31. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
32. Poor prognosis of gastric adenocarcinoma with decreased expression of AHRR.
Li YF; Wang DD; Zhao BW; Wang W; Yuan SQ; Huang CY; Chen YM; Zheng Y; Keshari RP; Xia JC; Zhou ZW
PLoS One; 2012; 7(8):e43555. PubMed ID: 22952704
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
34. MOR1 expression in gastric cancer: a biomarker associated with poor outcome.
Yao YS; Yao RY; Zhuang LK; Qi WW; Lv J; Zhou F; Qiu WS; Yue L
Clin Transl Sci; 2015 Apr; 8(2):137-42. PubMed ID: 25441763
[TBL] [Abstract][Full Text] [Related]
35. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Sun GG; Sheng SH; Jing SW; Hu WN
Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
[TBL] [Abstract][Full Text] [Related]
36. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.
Ren J; Xu S; Guo D; Zhang J; Liu S
Clin Transl Oncol; 2014 Jul; 16(7):668-74. PubMed ID: 24248895
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients.
Liu L; Yang Z; Zhang W; Yan B; Gu Q; Jiao J; Yue X
Tumour Biol; 2014 Sep; 35(9):8875-81. PubMed ID: 24894674
[TBL] [Abstract][Full Text] [Related]
40. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
